Low-dose Methylphenidate Monotherapy for Features of Attention-Deficit/Hyperactivity Disorder Secondary to Hereditary Cerebellar Ataxia.
Low-dose Methylphenidate Monotherapy for Features of Attention-Deficit/Hyperactivity Disorder Secondary to Hereditary Cerebellar Ataxia.
CNS Neurosci Ther. 2015 May 15;
Authors: Hu LY, Lin YL, Chang HS, Lu T, Lin WS
PMID: 25976218 [PubMed - as supplied by publisher]
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Hu LY, Lin YL, Chang HS, Lu T, Lin WS Tags: CNS Neurosci Ther Source Type: research
More News: ADHD | Ataxia | Brain | Concerta | Hyperactivity | Methylphenidate | Neurology | Neuroscience | Ritalin